COMMUNIQUÉS West-GlobeNewswire

-
Calidi Biotherapeutics Announces Establishment of Scientific Advisory Board to Support Development of CLD-401 and Advance its RedTail Platform for the Systemic Delivery of Targeted Genetic Medicine
22/10/2025 -
LifeMD Names Dr. Tara Scott as Ambassador and Clinical Advisor for its Women’s Health Program
22/10/2025 -
Collegium Announces Poster Presentations at the American Academy of Child & Adolescent Psychiatry and Neuroscience Education Institute Conferences
22/10/2025 -
Aardvark Therapeutics to Present Data on Pipeline Programs at Upcoming ObesityWeek
22/10/2025 -
R1 Launches Phare, Healthcare’s First Revenue Operating System
22/10/2025 -
DLH Demonstrates Cybersecurity Excellence with CMMC Level 2 Certification
22/10/2025 -
Alignment Health Plan Named a 2026 Best Insurance Company for Medicare Advantage Across All Its Markets by U.S. News & World Report
22/10/2025 -
Synergy CHC (NASDAQ: SNYR) Deepens FOCUSfactor® Expansion with Kroger, PriceSmart & Wakefern — Strengthening U.S., Canada, and Global Reach
22/10/2025 -
Noah Medical Expands Clinical Evidence for the Galaxy System With Two New Studies Presented at CHEST 2025
22/10/2025 -
CytoMed Therapeutics’ Chairman Increases Effective Holdings to 21.95%
22/10/2025 -
Sironax Announces Key Leadership Appointments to Advance Global Drug Discovery and Development
22/10/2025 -
Kyverna Therapeutics to Host Conference Call on Interim Phase 2 Data from KYSA-6 Study of KYV-101 in Generalized Myasthenia Gravis
22/10/2025 -
New Heartflow PCI Navigator to Equip Interventional Cardiologists with Pre-procedural Insights to Enable PCI Planning
22/10/2025 -
Madrigal Pharmaceuticals to Release Third-Quarter 2025 Financial Results and Host Webcast on November 4, 2025
22/10/2025 -
Vera Therapeutics to Host an Investor Call and Webcast to Provide an ORIGIN 3 Update on November 6, 2025 at 4:30 pm ET
22/10/2025 -
Turn Therapeutics Provides Shareholder Update Highlighting Continued Execution Across Clinical and Strategic Milestones
22/10/2025 -
Equillium to Host Ulcerative Colitis KOL Event on November 5, 2025
22/10/2025 -
Cassava Sciences Appoints Dawn C. Bir to the Board of Directors
22/10/2025 -
The Future of Discovery: Science News Spotlights Scientists to Watch
22/10/2025
Pages